Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
14,600,620
-
Shares change
-
+1,647,126
-
Total reported value, excl. options
-
$84,243,730
-
Value change
-
+$9,028,680
-
Put/Call ratio
-
19%
-
Number of buys
-
40
-
Number of sells
-
24
-
Price
-
$5.77
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2023
As of 30 Jun 2023 Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,600,620 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 84 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.